Close
ACHEMA MIDDLE EAST 2026

Scientists Create Successful Mass Production System for Bioengineered Livers

Researchers report creating a biologically accurate mass-production platform that overcomes major barriers to bioengineering human liver tissues suitable for therapeutic transplant into people. A team...

DNAtrix Announces First Pediatric Patient Treated with Oncolytic Virus DNX-2401

DNAtrix, a leader in the development of oncolytic virus immunotherapies for cancer, announced the intratumoral delivery of DNX-2401 to the first pediatric patient in...

Bayer extends research collaboration for cancer treatments

Bayer has extended its ongoing research collaboration with the Broad Institute of MIT and Harvard in the US by five years for the development...

AMPEL BioSolutions, Horizon Pharma plc, and Lupus Research Alliance Partner on Unique Clinical Trial for Patients with Lupus

AMPEL BioSolutions, a leading biomedical research firm based in Charlottesville, Va., Horizon Pharma plc and The Lupus Research Alliance today announced the launch of...

Grifols and the European Investment Bank sign an Euros 85 million long-term loan to support its R+D+i initiatives

The European Investment Bank (EIB) and Grifols signed an Euros 85 million loan to support the company's R+D+i initiatives focused on investigating new indications...

Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD

Sunovion Pharmaceuticals Inc announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution...

AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

AstraZeneca has announced positive top-line results of the phase IV ASCENT trial for Tudorza Pressair (aclidinium bromide 400 µg, twice-daily), a long-acting muscarinic antagonist...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...